Evaluating the Efficacy and Safety of AI Localization Models in Multidisciplinary Team Care for NSCLC
Evaluating the Efficacy and Safety of AI Localization Models in Multidisciplinary Team Care for NSCLC: a Prospective, Controlled Clinical Trial Protocol
The goal of this clinical trial is to evaluate the effectiveness and safety of a locally deployed artificial intelligence (AI) decision-support model in the multidisciplinary team (MDT) process for patients with non-small cell lung cancer (NSCLC).
The main questions it aims to answer :
What is the level of agreement between treatment recommendations generated by the AI model and those made by a traditional MDT? How often do clinicians modify their final treatment decision after reviewing the AI model's recommendation? Researchers will compare treatment plans from the traditional MDT (Arm 1), the AI model (Arm 2), and the clinician's final decision after reviewing the AI output (Arm 3) to assess consistency, decision modification rates, and clinical efficiency.
Participants will:
Have their clinical, imaging, and molecular data submitted to both the traditional MDT and the AI model for independent treatment recommendations Receive a final treatment plan determined by clinicians after reviewing both recommendations, with follow-up for safety and survival outcomes
研究概览
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:qing liang, Dr.
- 电话号码:+86 17863321987
- 邮箱:liangtsing99@163.com
学习地点
-
-
Guangdong
-
Guangzhou、Guangdong、中国、510000
- 招聘中
- Guangdong Provincial People's Hospital
-
接触:
- Wenzhao Zhong, Dr.
- 电话号码:+8613609777314
- 邮箱:13609777314@163.com
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Age ≥ 18 years;
- MDT (Multidisciplinary Team) discussion deems a systemic treatment plan necessary;
- Complete clinical, imaging, and molecular pathological data.
Exclusion Criteria:
- Stage I patients;
- Diagnosed with a thoracic tumor other than NSCLC;
- Lack of detailed medical data, or missing data;
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:AI-Assisted Multidisciplinary Team Decision-Making for Non-Small Cell Lung Cancer
|
The impact of artificial intelligence on clinicians' treatment plans
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Consistency rate
大体时间:Baseline(MDT 1 Day)
|
Consistency rate between Option 1 and Option 2 (calculated using Kappa value).
Consistency rate between Option 1 and Option 3 (decision modification rate).
|
Baseline(MDT 1 Day)
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
MDT Discussion Process Time
大体时间:Baseline(MDT Day 1)
|
Time from start to end of multidisciplinary team (MDT) discussion, measured immediately after MDT end.
|
Baseline(MDT Day 1)
|
|
Quality of AI Recommendations
大体时间:Baseline(MDT Day 1)
|
Physician-rated quality of AI recommendations using a Likert 5-point scale (1 = very poor, 5 = excellent).
|
Baseline(MDT Day 1)
|
|
Clinical Acceptability of AI
大体时间:Baseline(MDT Day 1)
|
Physician-rated clinical acceptability of AI recommendations using a Likert 5-point scale (1 = unacceptable, 5 = fully acceptable).
|
Baseline(MDT Day 1)
|
|
MDT Discussion Efficiency
大体时间:Baseline(MDT Day 1)
|
Physician-rated efficiency of MDT discussion process aided by AI using a Likert 5-point scale (1 = very inefficient, 5 = very efficient).
|
Baseline(MDT Day 1)
|
|
Process Convenience
大体时间:Baseline(MDT Day 1)
|
Physician-rated convenience of the AI-integrated workflow using a Likert 5-point scale (1 = very inconvenient, 5 = very convenient).
|
Baseline(MDT Day 1)
|
|
Added Value to Clinical Decision
大体时间:Baseline(MDT Day 1)
|
Physician-rated added value of AI to clinical decision-making using a Likert 5-point scale (1 = no added value, 5 = significant added value).
|
Baseline(MDT Day 1)
|
|
Learning and Training Value
大体时间:Baseline(MDT Day 1)
|
Physician-rated learning and training value of AI system using a Likert 5-point scale (1 = no value, 5 = high value).
|
Baseline(MDT Day 1)
|
|
Overall Satisfaction
大体时间:Baseline(MDT Day 1)
|
Physician-rated overall satisfaction with AI-assisted MDT using a Likert 5-point scale (1 = very dissatisfied, 5 = very satisfied).
|
Baseline(MDT Day 1)
|
|
Willingness to Use in Future
大体时间:Baseline(MDT Day 1)
|
Physician-rated willingness to use AI system in future clinical practice using a Likert 5-point scale (1 = definitely not willing, 5 = definitely willing).
|
Baseline(MDT Day 1)
|
|
Disease-Free Survival (DFS)
大体时间:3 years
|
Time from treatment initiation to disease recurrence or death from any cause, assessed every 3-6 months during 2-3 years follow-up.
|
3 years
|
|
Progression-Free Survival (PFS)
大体时间:3 years
|
Time from treatment initiation to disease progression or death from any cause, assessed every 3-6 months during 2-3 years follow-up.
|
3 years
|
|
Overall Survival (OS)
大体时间:3 years
|
Time from treatment initiation to death from any cause, assessed every 3-6 months during 2-3 years follow-up.
|
3 years
|
合作者和调查者
出版物和有用的链接
一般刊物
- Pillay B, Wootten AC, Crowe H, Corcoran N, Tran B, Bowden P, Crowe J, Costello AJ. The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literature. Cancer Treat Rev. 2016 Jan;42:56-72. doi: 10.1016/j.ctrv.2015.11.007. Epub 2015 Nov 24.
- Kim JK, Chua ME, Li TG, Rickard M, Lorenzo AJ. Novel AI applications in systematic review: GPT-4 assisted data extraction, analysis, review of bias. BMJ Evid Based Med. 2025 Sep 22;30(5):313-322. doi: 10.1136/bmjebm-2024-113066.
- Wiegand TLT, Jung LB, Gudera JA, Schuhmacher LS, Moehrle P, Rischewski JF, Mehrzad P, Jeong S, Nguyen LH, Poeschla M, Velezmoro LI, Kruk L, Dimitriadis K, Koerte IK. Demographic inaccuracies and biases in the depiction of patients by artificial intelligence text-to-image generators. NPJ Digit Med. 2025 Jul 19;8(1):459. doi: 10.1038/s41746-025-01817-6.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.